November 2017 - Volume 28 - Issue 10

  • Mels Sluyser, PhD
  • 0959-4973
  • 1473-5741
  • 10 / year
  • 142 of 217 Oncology
    136 of 256 Pharmacology & Pharmacy
  • 2.320

Current Issue Highlights



Extended topoisomerase 1 inhibition through liposomal irinotecan results in improved efficacy over topotecan and irinotecan in models of small-cell lung cancer

Leonard, Shannon C.; Lee, Helen; Gaddy, Daniel F.; More

Anti-Cancer Drugs. 28(10):1086-1096, November 2017.